Allergy Immunotherapy Shots: Your Visit-by-Visit Roadmap

With at-home SCIT, each weekly dose follows a consistent routine. Before injecting, you run a quick self-check from your care team's checklist — confirming you have no active allergy symptoms, your asthma is controlled (a peak-flow check if you have asthma), no recent illness, and no lingering reaction from your last dose. You then self-administer the injection subcutaneously — under the skin — in the back of your upper arm using a 26-27 gauge needle; it takes about 10-15 seconds. Next comes a mandatory 30-minute observation period: you keep your prescribed epinephrine auto-injector on hand and watch for any systemic reactions. Your first dose and every dose escalation are supervised live over Zoom by the prescribing allergist. After 30 minutes, if you feel fine, you're done — no waiting room and no travel time. Patients with multiple allergen vials may inject more than one site in the same session.

During conventional build-up, allergy shots are typically scheduled once per week, though some protocols use twice-weekly injections to speed the process. Each visit increments the allergen dose, usually by increasing the concentration of allergen extract in the injection. This gradual escalation continues for approximately 3-6 months (around 25-30 injections) until the target maintenance dose is reached. Faster alternatives include cluster immunotherapy — receiving 2-3 increasing doses on the same day, reaching maintenance in 4-8 weeks with roughly half as many clinic visits as conventional. Rush immunotherapy compresses build-up into 1-3 days but requires hospital-level supervision and premedication due to higher systemic reaction risk. Most US allergists use conventional weekly build-up.

Several activities and conditions can increase the risk of a reaction to allergy shots and may require postponing your injection. You should not exercise vigorously for at least 2 hours before and after your shot — physical activity increases blood flow and can accelerate allergen absorption, raising systemic reaction risk. Avoid alcohol before appointments. Tell your nurse if you have had any symptoms of illness, have uncontrolled asthma symptoms, or have recently used beta-blockers — a class of heart and blood pressure medications that interfere with epinephrine's ability to treat a reaction. During your peak pollen season, some allergists temporarily reduce your dose, so it is important to disclose if you are experiencing significant allergy symptoms on the day of your appointment. If you are pregnant or think you might be, discuss this with your allergist before continuing.

Missing appointments requires dose adjustments before your next injection, and the required reduction depends on how long you have been away. During build-up, missing up to 7 days typically allows continuing on schedule; a 2-3 week gap means repeating your last dose; a 3-4 week gap means stepping back one dose; and a gap of 90 or more days typically requires restarting from vial one. During maintenance, gaps of less than 5 weeks allow continuing normally; 5-7 weeks require a 25% reduction; 7-11 weeks require a roughly 45% reduction; and a gap of 3-4 months or more usually means restarting the entire SCIT course from the beginning. Always contact your allergist before your next appointment after any significant gap — these dose adjustment protocols exist for your safety and should not be skipped.

Yes — the 30-minute post-injection observation period is medically necessary, not optional or excessively cautious. The requirement exists because approximately 85% of systemic reactions to allergy shots occur within 30 minutes of injection, and anaphylaxis requires immediate treatment with epinephrine that only clinic-based staff can provide promptly. The mandatory wait is codified in the AAAAI/ACAAI Practice Parameter for precisely this reason — every injection is given in a setting equipped for anaphylaxis management because systemic reactions cannot be reliably predicted in advance. Some reactions appear to emerge only after the first few minutes of post-injection monitoring, making the full 30 minutes important even if the first 15 minutes are uneventful. Patients who leave before the observation period ends do so against medical advice.

The clearest indicator that allergy shots are working is reduced symptom severity during allergen exposure — less nasal congestion, sneezing, eye irritation, and asthma symptoms during seasons or environments that previously caused significant reactions. Most patients first notice this improvement within 3-6 months of reaching the maintenance dose, often coinciding with the first allergy season after achieving maintenance. The improvement tends to be gradual and cumulative — year two is typically better than year one, and year three better than year two. Many patients also notice they can reduce or eliminate rescue medications (antihistamines, nasal sprays) as treatment progresses. If symptoms are not meaningfully improved after 12 full months at the maintenance dose, a reassessment with your allergist is warranted to review allergen selection and dosing adequacy.

The injection itself involves a brief, sharp sensation similar to any subcutaneous injection — most patients describe it as a mild sting lasting a few seconds. The injection is given in the fatty tissue of the upper outer arm with a thin 26-27 gauge needle, which is finer than most standard blood draw needles. After the injection, mild redness, swelling, and itching at the injection site are common — occurring in 26-86% of patients — and typically peak at 30-60 minutes before resolving within a few hours. These local reactions are expected signs of immune activation, not a reason for concern unless the swelling is very large or persists for more than 24 hours. For patients with significant needle anxiety, cluster and rush protocols can reduce the total number of injections required, though each injection still involves the same brief discomfort.